Jean Ménager

770 total citations
20 papers, 616 citations indexed

About

Jean Ménager is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Jean Ménager has authored 20 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 2 papers in Physiology. Recurrent topics in Jean Ménager's work include Receptor Mechanisms and Signaling (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Ion channel regulation and function (4 papers). Jean Ménager is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Ion channel regulation and function (4 papers). Jean Ménager collaborates with scholars based in France, United States and Netherlands. Jean Ménager's co-authors include Adam Doble, Laurent Pradier, C. Guérémy, Marie‐Claude Burgevin, Jesús Bénavidès, A. Uzan, Erwan Bézard, C. Renault, G. Le Fur and C. Garret and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Journal of Neurochemistry.

In The Last Decade

Jean Ménager

20 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean Ménager France 15 426 366 78 53 38 20 616
Michael C. Hanna United States 9 528 1.2× 424 1.2× 64 0.8× 38 0.7× 40 1.1× 10 793
Elizabeth B. Hollingsworth United States 13 413 1.0× 403 1.1× 71 0.9× 40 0.8× 26 0.7× 18 684
A Ambrosini Italy 14 652 1.5× 526 1.4× 102 1.3× 29 0.5× 33 0.9× 24 884
Stéphanie Carvalho France 13 314 0.7× 295 0.8× 68 0.9× 42 0.8× 39 1.0× 16 632
Marie‐Claude Burgevin France 14 464 1.1× 492 1.3× 105 1.3× 53 1.0× 77 2.0× 24 750
Michael Finley United States 13 440 1.0× 211 0.6× 70 0.9× 31 0.6× 31 0.8× 34 653
Ann‐Cathrin Radesäter Sweden 11 429 1.0× 264 0.7× 164 2.1× 102 1.9× 23 0.6× 15 727
František Jurský Slovakia 12 367 0.9× 448 1.2× 83 1.1× 30 0.6× 22 0.6× 34 703
Antonio M. G. de Diego Spain 15 336 0.8× 242 0.7× 94 1.2× 40 0.8× 20 0.5× 31 586
Douglas S. Gregory United States 17 363 0.9× 276 0.8× 123 1.6× 35 0.7× 33 0.9× 28 830

Countries citing papers authored by Jean Ménager

Since Specialization
Citations

This map shows the geographic impact of Jean Ménager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Ménager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Ménager more than expected).

Fields of papers citing papers by Jean Ménager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Ménager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Ménager. The network helps show where Jean Ménager may publish in the future.

Co-authorship network of co-authors of Jean Ménager

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Ménager. A scholar is included among the top collaborators of Jean Ménager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Ménager. Jean Ménager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Delay‐Goyet, Philippe, Véronique Blanchard, Mati Lopez‐Grancha, et al.. (2016). SAR110894, a potent histamine H3‐receptor antagonist, displays disease‐modifying activity in a transgenic mouse model of tauopathy. Alzheimer s & Dementia Translational Research & Clinical Interventions. 2(4). 267–280. 17 indexed citations
2.
Pradier, Laurent, Caroline Cohen, Véronique Blanchard, et al.. (2013). P4–285: SAR228810: An antiprotofibrillar beta‐amyloid antibody designed to reduce risk of amyloid‐related imaging abnormalities (ARIA). Alzheimer s & Dementia. 9(4S_Part_20). 15 indexed citations
3.
Trouillas, Marina, David Duval, Xavier Gauthereau, et al.. (2008). Bcl2, a transcriptional target of p38α, is critical for neuronal commitment of mouse embryonic stem cells. Cell Death and Differentiation. 15(9). 1450–1459. 32 indexed citations
4.
Bassilana, Frédéric, J.M. Stutzmann, Cornelius T. Gross, et al.. (2005). Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson's disease. Neurobiology of Disease. 20(1). 93–103. 24 indexed citations
5.
Grinevich, Vladimir P., Sharon R. Letchworth, Jean Ménager, et al.. (2005). Heterologous Expression of Human α6β4β3α5 Nicotinic Acetylcholine Receptors: Binding Properties Consistent with Their Natural Expression Require Quaternary Subunit Assembly Including the α5 Subunit. Journal of Pharmacology and Experimental Therapeutics. 312(2). 619–626. 32 indexed citations
6.
Marvanová, Markéta, Jean Ménager, Erwan Bézard, et al.. (2003). Microarray analysis of nonhuman primates: validation of experimental models in neurological disorders. The FASEB Journal. 17(8). 1–19. 61 indexed citations
7.
Octave, Jean‐Noël, Rachid Essalmani, Bernadette Tasiaux, et al.. (2000). The Role of Presenilin-1 in the γ-Secretase Cleavage of the Amyloid Precursor Protein of Alzheimer's Disease. Journal of Biological Chemistry. 275(3). 1525–1528. 35 indexed citations
8.
Mercken, Luc, Françoise Apiou, Laurent Pradier, et al.. (1996). Molecular Cloning, Functional Expression, Pharmacological Characterization and Chromosomal Localization of the Human Metabotropic Glutamate Receptor Type 3. Neuropharmacology. 35(5). 523–530. 17 indexed citations
9.
Pradier, Laurent, et al.. (1994). Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.. Molecular Pharmacology. 45(2). 287–293. 46 indexed citations
10.
Ménager, Jean, et al.. (1994). The human galanin receptor: ligand-binding and functional characteristics in the Bowes melanoma cell line. European Journal of Pharmacology Molecular Pharmacology. 269(2). 139–147. 46 indexed citations
11.
Ménager, Jean, et al.. (1994). Inhibition of cAMP formation by galanin and the chimeric galanin peptides, in the human cell line, bowes. Neuropeptides. 26. 26–27. 1 indexed citations
12.
Ménager, Jean, et al.. (1993). Characterization of a Human NK1 Tachykinin Receptor in the Astrocytoma Cell Line U 373 MG. Journal of Neurochemistry. 60(3). 868–876. 56 indexed citations
13.
Ménager, Jean, François Clerc, B Amiranoff, et al.. (1993). Identification of galanin receptors on a human melanoma cell line. Neuropeptides. 24(4). 242–242. 1 indexed citations
14.
Doble, Adam, D. Girdlestone, O. Piot, et al.. (1992). Pharmacological characterization of RP 62203, a novel 5‐hydroxytryptamine 5‐HT2 receptor antagonist. British Journal of Pharmacology. 105(1). 27–36. 38 indexed citations
15.
Doble, Adam, et al.. (1992). 3H-RP 62203: IN VITRO 5-HT2 BINDING STUDIES.. Clinical Neuropharmacology. 15. 581B–581B. 2 indexed citations
16.
Doble, Adam, Marie‐Claude Burgevin, Jean Ménager, et al.. (1987). Photoaffinity labeling of peripheral-type benzodiazepine-binding sites.. Molecular Pharmacology. 31(1). 42–49. 71 indexed citations
17.
Doble, Adam, Marie‐Claude Burgevin, Jean Ménager, et al.. (1987). Partial Purification and Pharmacology of Peripheral-Type Benzodiazepine Receptors. Journal of Receptor Research. 7(1-4). 55–70. 12 indexed citations
18.
Bénavidès, Jesús, Jean Ménager, Marie‐Claude Burgevin, et al.. (1985). Characterization of solubilized “peripheral type” benzodiazepine binding sites from rat adrenals by using [3H]PK 11195, an isoquinoline carboxamide derivative. Biochemical Pharmacology. 34(2). 167–170. 28 indexed citations
19.
Doble, Adam, Jesús Bénavidès, Philìppe Bertrand, et al.. (1985). Dihydropyridine and peripheral type benzodiazepine binding sites: Subcellular distribution and molecular size determination. European Journal of Pharmacology. 119(3). 153–167. 72 indexed citations
20.
Keane, P.E., Jean Ménager, & M. Strolin Benedetti. (1981). The effect of monoamine oxidase A and B inhibitors on rat serum prolactin. Neuropharmacology. 20(12). 1157–1162. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael C. Hanna Breakdown of academic impact, for papers by Elizabeth B. Hollingsworth Breakdown of academic impact, for papers by A Ambrosini Breakdown of academic impact, for papers by Stéphanie Carvalho Breakdown of academic impact, for papers by Marie‐Claude Burgevin Breakdown of academic impact, for papers by Michael Finley Breakdown of academic impact, for papers by Ann‐Cathrin Radesäter Breakdown of academic impact, for papers by František Jurský Breakdown of academic impact, for papers by Antonio M. G. de Diego Breakdown of academic impact, for papers by Douglas S. Gregory
Rankless by CCL
2026